Biotech BioCryst Presents Data Demonstrating >99 Percent Suppression of Alternative Pathway Complement Activity with BCX9930 in C3G Patients August 29, 2022
Biotech Iovance Biotherapeutics Initiates Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma August 29, 2022
Biotech ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences August 29, 2022
Biotech CANCER Publishes Study Demonstrating Substantial Disease Burden for Patients with Systemic Mastocytosis August 29, 2022
Biotech U.S. Government Exercises Option to Purchase Additional RAPIVAB® (peramivir injection) from BioCryst for Pandemic Influenza Preparedness August 29, 2022
Biotech MAURICE icIEF ESTABLISHED AS A GREEN METHOD FOR CHARACTERIZATION OF AAV IDENTITY AND STABILITY August 29, 2022
Biotech Intellia Therapeutics to Present Interim Clinical Data from Ongoing Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema at the 2022 Bradykinin Symposium August 24, 2022
Biotech Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion August 24, 2022
Search
Biotech
August 29, 2022
August 29, 2022
August 29, 2022
August 29, 2022
August 29, 2022
August 29, 2022
August 29, 2022
August 24, 2022
August 24, 2022
August 24, 2022
